Back to Companies
BeOne Medicines Ltd.
ONCOTCCIK: 0001651308
Recent Form 4 activity at BeOne Medicines Ltd. (ONC) spans 50 filings across 17 insiders (all of them on the sell side). Purchases total $0 against $216.2M in sales — heavily weighted toward selling, for net sales of $216.2M. OYLER JOHN (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $130.5M by OYLER JOHN. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$279.6M
Purchases
$0
Sales
$216.2M
Unique Insiders
17
Recent Insider Trades
50 loaded
| Jul 24 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $542.4K |
| Jul 22 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $34.6M |
| Jul 17 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $20.2M |
| Jul 17 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $89.4M |
| Jul 14 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $44.6M |
| Jul 14 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $18.3M |
| Jul 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $200.8K |
| Jun 25 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $356.9K |
| Jun 25 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $933.6K |
| Jun 25 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $295.6K |
| Jun 18 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $156.9K |
| Jun 18 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $362.0K |
| Jun 18 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $980.7K |
| Jun 18 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $310.2K |
| Jun 15 | ONC BeOne Medicines Ltd. | Sharp Shalini | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Mooney Elizabeth Fisher | Director | Other | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Sawyers Charles Lazelle | Director | Other | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | BRANDICOURT OLIVIER | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Wang Xiaodong | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Riva Alessandro | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Mooney Elizabeth Fisher | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Sawyers Charles Lazelle | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Rosenberg Aaron | Chief Financial Officer | Sell | $162.6K |
| Jun 15 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $163.5K |
| Jun 15 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $501.4K |
| Jun 15 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $110.3K |
| Jun 15 | ONC BeOne Medicines Ltd. | HOOPER ANTHONY C | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | Sell | $43.5K |
| Jun 15 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $197.3K |
| Jun 15 | ONC BeOne Medicines Ltd. | Dugan Margaret | Director | Grant | $0 |
| Jun 10 | ONC BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | Sell | $36.9K |
| Jun 10 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $368.2K |
| Jun 10 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $1.3M |
| Jun 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $235.5K |
| Jun 10 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $399.7K |
| Jun 3 | ONC BeOne Medicines Ltd. | Yi Qingqing | Director | Sell | $65.6K |
| May 27 | ONC BeOne Medicines Ltd. | Riva Alessandro | Director | Sell | $65.6K |
| May 27 | ONC BeOne Medicines Ltd. | Dugan Margaret | Director | Sell | $65.6K |
| May 27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Insider | Sell | $262.0K |
| May 27 | ONC BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. | Director | Sell | $65.6K |
| Apr 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $103.4K |
| Mar 13 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $102.3K |
| Mar 10 | ONC BeOne Medicines Ltd. | Rosenberg Aaron | Chief Financial Officer | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Grant | $0 |
| Feb 6 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $580.2K |
| Jan 9 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $220.3K |
50 filings+